Oncobesity News Posts

China has 60 drugs under trial to rival Ozempic in US$150 billion weight-loss market
Illustration by Henry Wong. When Hong Kong office worker W.K. Chan began putting on weight as a teenager, her doctor said it was due to

This week in 5 numbers: Nearly a quarter of companies offer GLP-1 drug coverage for weight management
Post Content

Thoughts on $HIMS? Crash and burn, or rise like a phoenix?
With HIMS earnings call on the way (August 4th) I’ve been deciding which strategy to take. I was previously confident in my decision to buy

Weight Loss Drugs – The Hidden Side Effects You Need to Know
—– *Follow Us!* https://beacons.ai/instituteofhumananatomy #ozempic #glp1 #sideeffects

Visualizing the Top Emerging Technologies of 2025
See this visualization first on the Voronoi app. Use This Visualization Visualizing the Top 10 Emerging Tech of 2025 This was originally posted on our

Ozempic Is Changing More Than Waistlines as Scientists Wise Up to Concerning Side Effects
But GLP-1 drugs also offer many benefits beyond weight loss.

New GLP-1 Combos and Other Highlights From ADA 2025
This Medical News article is an interview with Raveendhara Bannuru, MD, PhD, vice president of medical affairs at the American Diabetes Association, about clinical highlights

👵 Ozempic Face: GLP-1 and Aesthetic Surgery
This scholarly article from Aesthetic Surgery Journal Open Forum discusses the phenomenon of “Ozempic Face,” a term used to describe the accelerated facial aging and volume loss experienced by some patients

Can Mounjaro and Zepbound Drive Another Strong Quarter for Eli Lilly?
Demand for Eli Lilly’s LLY blockbuster GLP-1 medicines — Mounjaro (for type II diabetes) and Zepbound (for obesity) — remains strong. Despite being on the

Potential of non-digestible polysaccharides as GLP-1 secretagogues: action mechanisms, structure-activity relationships and clinical applications
Publication date: 1 November 2025 Source: Carbohydrate Polymers, Volume 367 Author(s): Zhen-Zi Shang, Hui-Yu Ye, Qiang-Ming Li, Xue-Qiang Zha, Jian-Ping Luo

Antag says it is confident ahead of ‘imminent’ Phase 1 obesity readout for GIP blockade
Antag Therapeutics is taking an unusual, although not unknown, approach to obesity. Where drugs like Eli Lilly’s Zepbound and other compounds from Roche and Viking

Summer’s fast food wars hit their flow as McDonald’s vs. Popeyes wrap battle heats up
Popeyes; McDonalds; BI McDonald’s has brought back its popular Chicken Snack Wrap after nearly a decade. Popeyes is simultaneously promoting its chicken wrap, ramping up

The internet hates Botox and filler — but only when it looks bad
Olandria, Cierra, Belle-A, Chelley, Amaya, and Huda Love Island USA Season 7 | Kim Nunneley/Peacock It wouldn’t be a season of Love Island if viewers

Urgent warning over medications that can STOP working in the hot weather – with fatal consequences
WITH parts of the UK set to sizzle under highs of 34°C, health chiefs have issued a warning over medications that could stop working in

What is the ‘real‐world’ experience with fixed‐ratio combination therapy (insulin + GLP‐1 receptor agonist) in routine clinical practice? Take‐home messages for clinicians regarding key outcomes
Abstract Aims The fixed-ratio combinations (FRCs) of a basal insulin and glucagon-like peptide-1 receptor agonist (GLP-1 RA), IDegLira (insulin degludec/liraglutide) and iGlarLixi (insulin glargine/lixisenatide), offer

Are Weight Loss Drugs Worth the Costs and Risks?
Helping people with eating disorders is a laudable goal, but there remain unknown health risks associated with a clutch of new weight loss drugs –

Amanda Bynes Explains Why She Cant Wear Tooth Gems
Amanda Bynes has given fans a glimpse into her latest jewelry addition. Posting via her Instagram Stories on Thursday, July 10, the She’s The Man

Comprehensive GLP-1 Support Needed
I’m seeking comprehensive support for my GLP-1 journey, focusing on diet, fitness, and emotional well-being. I need guidance in several areas to ensure a holistic

The Truth About Weight Loss After 50
(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits Gateway

“Ozempic Face” Is Real. But There’s Skincare for That.
Accelerated skin aging is a side effect of GLP-1 medications, but experts say there are products that can help

Weight Loss Injections vs Liposuction: Choosing the Right Body Contouring Path
Discover the differences between weight loss injections and liposuction. Learn which method fits your needs with expert insights. In the quest for body contouring, many

Nordic Cold Chain Solutions Launches Nordic Express Pack: First Cold Chain Packaging Specifically Designed and Tested for GLP-1 Medications
HATFIELD, Pa.–(BUSINESS WIRE)–Nordic Cold Chain Solutions, a leading provider of temperature-controlled packaging and cold chain solutions, announces the launch of the Nordic Express Pack, the

Mice Bodies Can Make Their Own Ozempic Now. Are Humans Next?
Pharmaceutical GLP-1 drugs like Ozempic and Wegovy have thus far proven to help regulate blood sugar and curb appetites. They are helping people shed pounds

New DoseSpot Analysis of 100,000 GLP-1 Prescriptions Finds That Patients Overpaid by $10.2M Collectively
92 percent of prescriptions could have been filled at a lower price, with better information on pricing, dispensing options and manufacturer cost-savings programs DoseSpot, which

✨ GLP-1s and Post-Weight Loss Plastic Surgery Trends
There is growing evidence—especially in the plastic surgery community—that the recent surge in GLP‑1 medications (like Ozempic, Wegovy, Mounjaro) for weight loss is fueling a

Viking Therapeutics: What’s Next After GLP-1 Hype Dies Down And Competition Intensifies

Weight loss drugs linked with growing number of side effects
The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are reporting. In very rare

I can’t go to work & am scared to move from the loo because of Mounjaro… but people say it’s down to WHERE I’m injecting
A MOUNJARO user has claimed that after 19 weeks of injecting, she is “too scared to move away from the toilet” as a result of

Viking Therapeutics: What’s Next After GLP-1 Hype Dies Down And Competition Intensifies

The golden dose of Mounjaro that helps you shift the MOST weight – and why it’s OK to still be hungry on the jab
EXPERTS have revealed the golden dose of Mounjaro that helps shift the most weight – and it’s not the highest one. Weight loss jab users

I’ve lost 5 stone on Mounjaro but have a ‘painful’, ‘burning’ side effect no one talks about – it’s driving me crazy
A WOMAN who dropped five stone using Mounjaro has warned other users of a ‘painful’ side effect that’s making her life hell. Ann, who shares

Glucagon‐like peptide‐1 is involved in fasting and postprandial blood flow regulation of subcutaneous adipose tissue
Abstract Aims Glucagon-like peptide 1 (GLP-1) is a gastrointestinal hormone with pleiotropic functions, including vasodilatory and vasculoprotective effects. As GLP-1 increases after a meal, it

Opinion: STAT+: How to evaluate GLP-1s and Medicare costs? Here’s one idea
Today, more than 40% of adults over 60 are considered obese, fueling chronic disease and straining Medicare’s budget. With the price tag for obesity-related care

Svelteness in China is a US$150 billion market, with dozens of drug producers vying for it
Vials of Eli Lilly’s Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss, are seen in a fridge at a

🧪Decoding GLP-1 Scams: A Consumer’s Guide
This post is to make alerts consumers to various deceptive practices surrounding GLP-1 medications, which are often used for weight loss and diabetes management. It highlights

Ozempic and Other GLP-1 Side Effects May Outweigh the Benefits
Learn how the benefits of GLP-1s may be outweighed by the risks.

Ciba Health Launches Nation’s First GLP-1 Step-Down Program, Addressing Post-Medication Metabolic Health
What You Should Know: – Ciba Health today announced the launch of its new GLP-1 Step-Down Program, marking the first national offering designed to guide

Is Novo Nordisk Increasing Dosage to Defend Wegovy’s Edge in Obesity?
Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking approval for a new and higher dose of

These Genetically Modified Mice Make Their Own ‘Ozempic’
Would you get a one-time genetic modification such that you’d never have to take a GLP-1 drug for weight loss ever again?

GLP-1 is changing taste: How can food makers reignite flavour?
GLP-1 drugs alter taste perceptions, challenging food makers to adapt by enhancing umami flavours, balancing sweetness, and focusing on nutrient-dense, portion-controlled products.